Alternative splicing of the p53 tumor suppressor gene in the Molt-4 T-lymphoblastic leukemia cell line
Abstract
The expression of the p53 tumor suppressor gene in ten human cell lines (nine cancers and one normal) was studied using reverse transcription, polymerase chain reaction (PCR) and direct sequencing. Using P53U and P53D primers for amplifying a 371-base pair (bp) target fragment spanning exons 7-10 of p53 cDNA, normal-sized PCR products were amplified from 9 cell lines but not from the Hep3B hepatocellular carcinoma (HCC) cell line. An additional larger band (504 bp) was observed for the Molt-4 T-lymphoblastic leukemia cell line. Employing P531 and P53D primers which flank a 76-bp p53 cDNA fragment, 76 bp as well as 209 bp products were generated by PCR of Molt-4 cDNA. Direct sequencing of the 504 bp and 209 bp bands confirmed the presence of a 133 bp insertion between exons 9 and 10 in the aberrant transcript. This insertion was homologous to a 130-bp sequence within the wild-type p53 intron 9, except for 2 point mutations and 3 base insertions. Sequencing of P53U/P53D PCR products of Molt-4 genomic DNA revealed an 8 bp deletion just downstream to the 133 bp insertion, creating a novel donor splicing site within intron 9. This site, coupled with an inherent acceptor splicing site just upstream to the 133 bp insertion, suggests that the 133 bp stretch represents an alternative exon. The occurrence of a termination signal within this alternative transcript is predicted to culminate in a truncated p53 translational product. The sequences of the 371 bp PCR products of Molt-4, HT-1…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The RAJI cell line harbors the loss-of-function mutant alleles R213Q and Y234H.
“The cell line RAJI, which harbors the loss-of-function mutant alleles R213Q and Y234H [34–36] for p53 targets including TLR3 and p21 (Supplementary Figure S4A), was treated with the reactivating drugs RITA [36] and PRIMA-1 [37] as well as with the anticancer drugs doxorubicin (DXR) and 5-fluorouracil (5FU) to induce p53.”
From Ligand dependent restoration of human TLR3 signaling and death in p53 mutant cells (2016) · cites this paper as [34]
Cites
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138 · see citing works
A catalogue of splice junction sequences
Mount, S. M. (1982) · Nucleic Acids Research · doi:10.1093/nar/10.2.459 · Cited by 3,881 · see citing works
The p53 tumour suppressor gene
Levine, A. J., Momand, J. A., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,785 · see citing works
Vogelstein, B. (1992) · Cell · doi:10.1016/0092-8674(92)90421-8 · Cited by 1,862 · see citing works
Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
Paillerets, B. B., Kew, M. C., Wands, J. R., & Öztürk, M. (1991) · Nature · doi:10.1038/350429a0 · Cited by 1,433 · see citing works
Oncogenic Forms of p53 Inhibit p53-Regulated Gene Expression
Kern, S. E., Pietenpol, J., Thiagalingam, S., Seymour, A., Kinzler, K. W., & Vogelstein, B. (1992) · Science · doi:10.1126/science.1589764 · Cited by 940 · see citing works
Regulation of the specific DNA binding function of p53
Hupp, T. R., Meek, D. W., Midgley, C., & Lane, D. P. (1992) · Cell · doi:10.1016/0092-8674(92)90562-q · Cited by 905 · see citing works
Milner, J., & Medcalf, E. (1991) · Cell · doi:10.1016/0092-8674(91)90384-b · Cited by 612 · see citing works
Chiba, I., Takahashi, T., Nau, M. M., D'Amico, D., Dt, C., Mitsudomi, T., Buchhagen, D. L., Carbone, D. P., Piantadosi, S., & KOGA, H. (1990) · PubMed · Cited by 514 · see citing works
Abnormal structure and expression of p53 gene in human hepatocellular carcinoma.
Paillerets, B. B., Galvin, K. M., Liang, T. J., Isselbacher, K. J., Wands, J. R., & Öztürk, M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1973 · Cited by 415 · see citing works
Rapid and quantitative preparation of cytoplasmic RNA from small numbers of cells
Gough, N. M. (1988) · Analytical Biochemistry · doi:10.1016/0003-2697(88)90164-9 · Cited by 403 · see citing works
Frequent Mutations in the p53 Tumor Suppressor Gene in Human Leukemia T-Cell Lines
Cheng, J. F., & Haas, M. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.10.5502-5509.1990 · Cited by 316 · see citing works
p53 point mutation in HPV negative human cervical carcinoma cell lines.
Crook, T., Wrede, C. D., & Vousden, K. H. (1991) · PubMed · Cited by 272 · see citing works
Mechanisms of p53 loss in human sarcomas.
Mulligan, L. M., Matlashewski, G., Scrable, H. J., & Cavenee, W. K. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.15.5863 · Cited by 268 · see citing works
Signals for the selection of a splice site in pre-mRNA
Ohshima, Y., & Gotoh, Y. (1987) · Journal of Molecular Biology · doi:10.1016/0022-2836(87)90647-4 · Cited by 246 · see citing works
Levine, A. J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205143262008 · Cited by 218 · see citing works
High frequency of somatically acquired p53 mutations in small-cell lung cancer cell lines and tumors
Simmons Cancer Center (1993) · Lung Cancer · doi:10.1016/0169-5002(93)90526-4 · Cited by 209 · see citing works
Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer
Branch, N.-N. M. O. (1991) · Lung Cancer · doi:10.1016/0169-5002(91)90309-t · Cited by 209 · see citing works
Stürzbecher, H. W., Brain, R., Addison, C. M., Rudge, K., Remm, M., Grimaldi, M., Keenan, E., & Jenkins, J. R. (1992) · PubMed · Cited by 191 · see citing works
Molecular Basis for Heterogeneity of the Human p53 Protein
Harris, N., Brill, E., Shohat, O., Prokocimer, M., Wolf, D., Arai, N., & Rotter, V. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.12.4650 · Cited by 171 · see citing works
Eva, A., Tronick, S. R., Gol, R., Pierce, J. H., & Aaronson, S. A. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.16.4926 · Cited by 169 · see citing works
Murakami, Y., Hayashi, K., & Sekiya, T. (1991) · PubMed · Cited by 160 · see citing works
Black, D. L. (1991) · Genes & Development · doi:10.1101/gad.5.3.389 · Cited by 147 · see citing works
Immunologically Distinct p53 Molecules Generated by Alternative Splicing
Arai, N., Nomura, D., Yokota, K., Wolf, D., Brill, E., Shohat, O., & Rotter, V. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.9.3232 · Cited by 126 · see citing works
Takahashi, T., D'Amico, D., Chiba, I., Buchhagen, D. L., & Minna, J. D. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114710 · Cited by 124 · see citing works
Analysis of the p53 gene in human uterine carcinoma cell lines.
Yaginuma, Y., & Westphal, H. (1991) · PubMed · Cited by 106 · see citing works
Hensel, C. H., Xiang, R. H., Sakaguchi, A. Y., & Naylor, S. L. (1991) · PubMed · Cited by 83 · see citing works
Tacke, R., & Goridis, C. (1991) · Genes & Development · doi:10.1101/gad.5.8.1416 · Cited by 69 · see citing works
Duthu, A., Debuire, B., Romano, J., Ehrhart, J., Fiscella, M., May, E., Appella, E., & May, P. (1992) · PubMed · Cited by 57 · see citing works
Alternatively spliced p53 RNA in transformed and normal cells of different tissue types
Han, K., & Kulesz-Martin, M. F. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.8.1979 · Cited by 57 · see citing works
Tham, K. M., Chow, V. T. K., Singh, P. J., Tock, E. P. C., Ching, K. C., Lim-Tan, S. K., Sng, I., & Bernard, H. (1991) · American Journal of Clinical Pathology · doi:10.1093/ajcp/95.5.638 · Cited by 52 · see citing works
Self-citationGerm-line splicing mutation of the p53 gene in a cancer-prone family.
Warneford, S., Witton, L. J., Townsend, M., Rowe, P. B., Reddel, R. R., Dalla‐Pozza, L., & Symonds, G. P. (1992) · PubMed · Cited by 46 · see citing works
Foti, A., Bar‐Eli, M., Ahuja, H., & Cline, M. J. (1990) · British Journal of Haematology · doi:10.1111/j.1365-2141.1990.tb07849.x · Cited by 39 · see citing works
Point mutation of the p53 gene resulting in splicing inhibition in small cell lung carcinoma
Sameshima, Y., Akiyama, T., Mori, N., Mizoguchi, H., Toyoshima, K., Sugimura, T., Terada, M., & Yokota, J. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80091-9 · Cited by 34 · see citing works
Greenberg, J., González‐Sarmiento, R., Arthur, D., Wilkowski, C., Streifel, B., & Kersey, J. (1988) · Blood · doi:10.1182/blood.v72.5.1755.1755 · Cited by 32 · see citing works
Rio, D. C. (1992) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(92)90010-a · Cited by 26 · see citing works
Soudon, J., de Fromentel, C. C., Bernard, O., & Larsen, C. (1991) · PubMed · Cited by 16 · see citing works
Flagged first, then by citations
9 of the 46 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Nonsense-mediated decay approaches the clinic
Holbrook, J. A., Neu‐Yilik, G., Hentze, M. W., & Kulozik, A. E. (2004) · Nature Genetics · doi:10.1038/ng1403 · Cited by 597 · see citing works
Murray-Zmijewski, F., Lane, D. P., & Bourdon, J. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401914 · Cited by 518 · see citing works
Analysis of TP53 Mutation Status in Human Cancer Cell Lines: A Reassessment
Leroy, B., Girard, L., Hollestelle, A., Minna, J. D., Gazdar, A. F., & Soussi, T. (2014) · Human Mutation · doi:10.1002/humu.22556 · Cited by 224 · see citing works
p53 Isoforms: An Intracellular Microprocessor?
Khoury, M. P., & Bourdon, J. (2011) · Genes & Cancer · doi:10.1177/1947601911408893 · Cited by 167 · see citing works
Lee, B. M., Lee, S. K., & Kim, H. S. (1998) · Cancer Letters · doi:10.1016/s0304-3835(98)00227-4 · Cited by 157 · see citing works
Schreiber, M., Muller, W. J., Singh, G., & Graham, F. L. (1999) · Oncogene · doi:10.1038/sj.onc.1202466 · Cited by 145 · see citing works
The Splicing Factor U1C Represses EWS/FLI-mediated Transactivation
Knoop, L. L., & Baker, S. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001661200 · Cited by 130 · see citing works
Wouters, B. G., Sy, A. M., & Skarsgard, L. D. (1996) · Radiation Research · doi:10.2307/3579302 · Cited by 120 · see citing works
EWS/FLI Alters 5′-Splice Site Selection
Knoop, L. L., & Baker, S. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008950200 · Cited by 106 · see citing works
Hofstetter, G., Berger, A., Fiegl, H., Slade, N., Zorić, A., Holzer, B., Schuster, E., Möbus, V. J., Reimer, D., Daxenbichler, G., et al. (2010) · Oncogene · doi:10.1038/onc.2009.482 · Cited by 82 · see citing works
Leong, W. F., & Chow, V. T. K. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00644.x · Cited by 81 · see citing works
Self-citationExpression of p53 isoforms in squamous cell carcinoma of the head and neck
Boldrup, L., Bourdon, J., Coates, P. J., Sjöström, B., & Nylander, K. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2006.10.019 · Cited by 81 · see citing works
O'Donnell, P. P., Guo, W.-X., Reynolds, C. P., & Maurer, B. A. (2002) · Leukemia · doi:10.1038/sj.leu.2402485 · Cited by 81 · see citing works
p53: link to the past, bridge to the futurePreprint
Mills, A. A. (2005) · Genes & Development · doi:10.1101/gad.1362905 · Cited by 81 · see citing works
Ghigna, C., Moroni, M., Porta, C., Riva, S., & Biamonti, G. (1998) · PubMed · Cited by 80 · see citing works
Bourdon, J. (2007) · Current Pharmaceutical Biotechnology · doi:10.2174/138920107783018444 · Cited by 76 · see citing works
de la Fuente, J., Ayoubi, P. J., Blouin, E. F., Almazán, C., Naranjo, V., & Kocan, K. M. (2004) · Cellular Microbiology · doi:10.1111/j.1462-5822.2004.00485.x · Cited by 75 · see citing works
p53 isoforms - A conspiracy to kidnap p53 tumor suppressor activity?
Marcel, V., & Hainaut, P. L. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8336-3 · Cited by 73 · see citing works
Irradiation Induces WAF1 Expression through a p53-independent Pathway in KG-1 Cells
Akashi, M., Hachiya, M., Osawa, Y., Spirin, K. S., Suzuki, G., & Koeffler, H. P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.32.19181 · Cited by 67 · see citing works
Endlich, B., Radford, I. R., Forrester, H. B., & Dewey, W. C. (2000) · Radiation Research · doi:10.1667/0033-7587(2000)153[0036:cvtlms]2.0.co;2 · Cited by 66 · see citing works
Kerstens, H. M. J., Robben, J. C. M., Poddighe, P. J., Melchers, W. J. G., Boonstra, H., de Wilde, P. C. M., Macville, M. V. E., & Hanselaar, A. G. J. M. (2000) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540004800515 · Cited by 64 · see citing works
Pierelli, L., Marone, M., Bonanno, G., Mozzetti, S., Rutella, S., Roberta Morosetti, A., Rumi, C., Mancuso, S., Leone, G. G. M., & Scambia, G. (2000) · Blood · doi:10.1182/blood.v95.10.3001 · Cited by 63 · see citing works
Liew, K., & Chow, V. T. K. (2005) · Journal of Virological Methods · doi:10.1016/j.jviromet.2005.07.003 · Cited by 57 · see citing works
Self-citationExpression of p16INK4A and p14ARF in hematological malignancies
Taniguchi, T., Chikatsu, N., Takahashi, S., Fujita, A., Uchimaru, K., Asano, S., Fujita, T., & Motokura, T. (1999) · Leukemia · doi:10.1038/sj.leu.2401557 · Cited by 55 · see citing works
Leong, W. F., Tan, H., Ooi, E. E., Koh, D. R., & Chow, V. T. K. (2005) · Microbes and Infection · doi:10.1016/j.micinf.2004.11.004 · Cited by 53 · see citing works
Self-citationKuwabara, M., Takahashi, K., & Inanami, O. (2003) · Journal of Radiation Research · doi:10.1269/jrr.44.203 · Cited by 51 · see citing works
Hamard, P.-J., Lukin, D. J., & Manfredi, J. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.331298 · Cited by 48 · see citing works
The EWS/NOR1 Fusion Gene Product Gains a Novel Activity Affecting Pre-mRNA Splicing
Ohkura, N., Yaguchi, H., Tsukada, T., & Yamaguchi, K. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109018200 · Cited by 47 · see citing works
Susceptibility to cytosine arabinoside (Ara-C)-induced cytotoxicity in human leukemia cell lines
Kanno, S. (2004) · Toxicology Letters · doi:10.1016/j.toxlet.2004.04.014 · Cited by 43 · see citing works
Disruption of Tacc3 function leads to in vivo tumor regression
Yao, R., Natsume, Y., Saiki, Y., Shioya, H., Takeuchi, K., Yamori, T., Toki, H., Aoki, I., Saga, T., & Noda, T. (2011) · Oncogene · doi:10.1038/onc.2011.235 · Cited by 40 · see citing works
DENN, a novel human gene differentially expressed in normal and neoplastic cells
Chow, V. T. K., & Lee, S. S. (1996) · DNA sequence · doi:10.3109/10425179609020873 · Cited by 38 · see citing works
Self-citationLigand dependent restoration of human TLR3 signaling and death in p53 mutant cells
Menendez, D., Lowe, J. M., Snipe, J., & Resnick, M. A. (2016) · Oncotarget · doi:10.18632/oncotarget.11210 · Cited by 31 · see citing works
Harada, K., Yamada, A., Yang, D., Itoh, K., & Shichijo, S. (2001) · International Journal of Cancer · doi:10.1002/ijc.1391 · Cited by 30 · see citing works
Sleiman, R. J., & Stewart, B. W. (2000) · PubMed · Cited by 30 · see citing works
Alberdi, P., Espinosa, P. J., Cabezas‐Cruz, A., & de la Fuente, J. (2016) · Veterinary Sciences · doi:10.3390/vetsci3030015 · Cited by 28 · see citing works
Afshin Samali, A., Gilje, B., Døskeland, S. O., Cotter, T. G., & Houge, G. (1997) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400246 · Cited by 27 · see citing works
Phoon, M. C., desBordes, C., Howe, J. L. C., & Chow, V. T. K. (2001) · Cell Biology International · doi:10.1006/cbir.2001.0733 · Cited by 27 · see citing works
Self-citationLeong, P. W. F., Liew, K., Lim, W., & Chow, V. T. K. (2002) · Virology · doi:10.1006/viro.2002.1353 · Cited by 23 · see citing works
Self-citationChow, V. T. K., & Quek, H. H. (1996) · Gene · doi:10.1016/0378-1119(95)00738-5 · Cited by 22 · see citing works
Self-citationAn in-vitro evaluation of the polo-like kinase inhibitor GW843682X against paediatric malignancies
Spaniol, K., Boos, J., & Lanvers‐Kaminsky, C. (2011) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e3283454526 · Cited by 21 · see citing works
Correlation between Unirradiated Cell TP53 Protein Levels and Radiosensitivity in MOLT-4 Cells
Nakano, H., & Shinohara, K. (1999) · Radiation Research · doi:10.2307/3580207 · Cited by 20 · see citing works
Chan, W. M., & Poon, R. Y. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3602 · Cited by 18 · see citing works
Šmardová, J., Pavlová, Š., Svitáková, M., Grochová, D., & Ravčuková, B. (2005) · Oncology Reports · doi:10.3892/or.14.4.901 · Cited by 18 · see citing works
Choi, M. J., Lee, J. W., & Lee, B. M. (1996) · Journal of Toxicology and Environmental Health · doi:10.1080/00984108.1996.11667601 · Cited by 18 · see citing works
Marone, M., Pierelli, L., Mozzetti, S., Masciullo, V., Bonanno, G., Roberta Morosetti, A., Rutella, S., Battaglia, A., Rumi, C., Mancuso, S., et al. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02227.x · Cited by 17 · see citing works
Gene expression profiling in MOLT-4 cells during gamma-radiation-induced apoptosis
Lindgren, T., Stigbrand, T. I., Riklund, K., Johansson, L. F., & Eriksson, D. (2012) · Tumor Biology · doi:10.1007/s13277-012-0329-z · Cited by 15 · see citing works
Vasconcelos, O. M., Sivakumar, K., Dalakas, M. C., Quezado, M., Nagle, J. W., Leon‐Monzon, M., Dubnick, M., Gajdusek, D. C., & Goldfarb, L. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.22.10322 · Cited by 15 · see citing works
Dubner, D., Pérez, M. D. R., Michelin, S., Bourguignon, M., Moreau, P., Carosella, E. D., & Gisone, P. A. (2004) · International Journal of Radiation Biology · doi:10.1080/09553000412331283506 · Cited by 12 · see citing works
Creation of a human T-ALL cell line online database
Squiban, B., Ahmed, S. T., & Frazer, J. K. (2017) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2017.1300896 · Cited by 9 · see citing works
Gale, J. M., Romero, C. P., Tafoya, G. B., & Conia, J. (2003) · Clinical Chemistry · doi:10.1373/49.3.415 · Cited by 5 · see citing works
Chow, V. T. K., Slim, S., & Tock, E. P. C. (1994) · Acta Oncologica · doi:10.3109/02841869409083925 · Cited by 3 · see citing works
Self-citationT-Cell Acute Lymphoblastic Leukemia and Natural Killer Cell Lines
Findley, H. W., Johnson, H. L., & Smith, S. D. (2002) · Human cell culture · doi:10.1007/0-306-46877-8_5 · Cited by 1 · see citing works
Bourdon, J., & Lane, D. P. (2007) · The Cancer Handbook · doi:10.1002/9780470025079.chap223 · Cited by 1 · see citing works
Parallel networks that govern the transcriptional response to stress
Durham, S. A. (2022) · doi:10.54014/9v8x-vd6d · Cited by 1 · see citing works
p63 and potential p63 targets in squamous cell carcinoma of the head and neck
Boldrup, L. (2008) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Menéndez, D., Nguyen, T., Snipe, J. R., & Resnick, M. A. (2023) · doi:10.1158/1541-7786.22517539.v1
Menéndez, D., Nguyen, T., Snipe, J. R., & Resnick, M. A. (2023) · doi:10.1158/1541-7786.22517539
Role of p53 and its isoforms in the expression of FGF-2 and tumoral neovascularization
Bernard, H. (2010) · Discovery Research Portal (University of Dundee)
- Authors
- Chow, V. T. K., Quek, H. H., & Tock, E. P. C.
- Affiliations
- National University of Singapore (SG)
- Corresponding author
- Chow, Vincent T.K.
- ORCID
- Chow, Vincent T.K.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 1993-09
- Volume
- 73
- Issue
- 2-3
- Pages
- 141-148
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2000937841
- Cited by
- 59
- References
- 46
- Citations by year
- 2023: 2 · 2022: 1 · 2017: 1 · 2016: 2 · 2014: 1 · 2012: 2
- FWCI
- 0.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Letters (publishedVersion)
- PubMed (publishedVersion)
- National University of Singapore (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Keywords
- p53, alternative splicing, MOLT-4 cells, T-cell acute lymphoblastic leukemia, alternative exons, TP53 mutation, hepatocellular carcinoma, Burkitt lymphoma, tumor suppressor gene expression
- MeSH terms
- Amino Acid Sequence, Base Sequence, DNA, Neoplasm, Humans, Molecular Sequence Data, Transcription, Genetic, Tumor Cells, Cultured, Leukemia-Lymphoma, Adult T-Cell, Gene Expression, Polymerase Chain Reaction, Genes, p53, Alternative Splicing, Sequence Analysis, DNA
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review